Abstract
Malignant ovarian tumours of the fibrothecoma group are rare. The clinicopathological features of a case of ovarian malignant fibrothecoma in which there was metastatic disease in the small intestine and peritoneum at presentation are described. A number of differential diagnoses were considered but positive immunohistochemical staining of the resected ovarian and small intestinal neoplasms with anti-inhibin was of value in confirming a sex cord-stromal tumour and in excluding other lesions. The two tumours were also ultrastructurally identical. Classical malignant fibrothecomas are said to show four or more mitotic figures per 10 high power fields (HPF). Although the intestinal secondary was mitotically active, the primary ovarian tumour contained only one to two mitoses per 10 HPF, showing that formal mitotic counts are not an absolute indicator of malignant behaviour in this group of tumours.
Full text
PDF
Images in this article
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Flemming P., Wellmann A., Maschek H., Lang H., Georgii A. Monoclonal antibodies against inhibin represent key markers of adult granulosa cell tumors of the ovary even in their metastases. A report of three cases with late metastasis, being previously misinterpreted as hemangiopericytoma. Am J Surg Pathol. 1995 Aug;19(8):927–933. doi: 10.1097/00000478-199508000-00008. [DOI] [PubMed] [Google Scholar]
- LYDAY R. O. Fibroma of the ovary with abdominal implants. Am J Surg. 1952 Dec;84(6):737–738. doi: 10.1016/0002-9610(52)90144-x. [DOI] [PubMed] [Google Scholar]
- McCluggage W. G., Maxwell P., Sloan J. M. Immunohistochemical staining of ovarian granulosa cell tumors with monoclonal antibody against inhibin. Hum Pathol. 1997 Sep;28(9):1034–1038. doi: 10.1016/s0046-8177(97)90056-3. [DOI] [PubMed] [Google Scholar]
- McLachlan R. I., Robertson D. M., Healy D. L., Burger H. G., de Kretser D. M. Circulating immunoreactive inhibin levels during the normal human menstrual cycle. J Clin Endocrinol Metab. 1987 Nov;65(5):954–961. doi: 10.1210/jcem-65-5-954. [DOI] [PubMed] [Google Scholar]
- Miles P. A., Kiley K. C., Mena H. Giant fibrosarcoma of the ovary. Int J Gynecol Pathol. 1985;4(1):83–87. doi: 10.1097/00004347-198501000-00007. [DOI] [PubMed] [Google Scholar]
- Nouwen E. J., Pollet D. E., Eerdekens M. W., Hendrix P. G., Briers T. W., De Broe M. E. Immunohistochemical localization of placental alkaline phosphatase, carcinoembryonic antigen, and cancer antigen 125 in normal and neoplastic human lung. Cancer Res. 1986 Feb;46(2):866–876. [PubMed] [Google Scholar]
- Prat J., Scully R. E. Cellular fibromas and fibrosarcomas of the ovary: a comparative clinicopathologic analysis of seventeen cases. Cancer. 1981 Jun 1;47(11):2663–2670. doi: 10.1002/1097-0142(19810601)47:11<2663::aid-cncr2820471124>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- Tsuji T., Kawauchi S., Utsunomiya T., Nagata Y., Tsuneyoshi M. Fibrosarcoma versus cellular fibroma of the ovary: a comparative study of their proliferative activity and chromosome aberrations using MIB-1 immunostaining, DNA flow cytometry, and fluorescence in situ hybridization. Am J Surg Pathol. 1997 Jan;21(1):52–59. doi: 10.1097/00000478-199701000-00006. [DOI] [PubMed] [Google Scholar]
- Waxman M., Vuletin J. C., Urcuyo R., Belling C. G. Ovarian low-grade stromal sarcoma with thecomatous features: a critical reappraisal of the so-called "malignant thecoma". Cancer. 1979 Dec;44(6):2206–2217. doi: 10.1002/1097-0142(197912)44:6<2206::aid-cncr2820440633>3.0.co;2-n. [DOI] [PubMed] [Google Scholar]